Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F73YJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,885
Award facts
- Contract value 100% obligated
- $14,884.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,884.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. The award, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a single delivery order with no set-aside designation, indicating full and open competition. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare systems worldwide.
Enbrel (etanercept) is a biologic immunosuppressant medication used primarily for treating rheumatoid arthritis, psoriatic arthritis, and other inflammatory conditions across military treatment facilities and veteran healthcare programs. As a major pharmaceutical distributor specializing in federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications through its DLA contract vehicle, enabling efficient fulfillment of critical pharmaceutical needs across the Defense Health Agency and related federal healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the routine nature of pharmaceutical supply orders supporting ongoing military medical operations.
Quick answers
Who was awarded contract SPE2DR26F73YJ?
SPE2DR26F73YJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F73YJ worth?
The government has obligated $14,885 on SPE2DR26F73YJ.
Is contract SPE2DR26F73YJ an order under another contract?
Yes. SPE2DR26F73YJ is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73YJ competed?
The extent of competition for SPE2DR26F73YJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award